27771746|t|Identification and functional analysis of the GTPV bidirectional promoter region
27771746|a|The goat pox chick embryo-attenuated virus (GTPV) has been developed as an effective vaccine that can elicit protective immune responses. It possesses a large genome and a robust ability to express exogenous genes. Thus, this virus is an ideal vector for recombinant live vaccines for infectious diseases in ruminant animals. In this study, we identified a novel bidirectional promoter region of GTPV through screening named PbVV(±). PbVV(±) is located between ETF-l and VITF-3, which are transcribed in opposite directions. A new recombinant goat pox virus (rGTPV) was constructed, in which duplicate PbVV(+) was used as a promoter element to enhance Brucella OMP31 expression, and duplicate PbVV (-) was used as a promoter element to regulate enhanced green fluorescent protein (EGFP) at the same time as the selection marker. PbVV(-) promoter activity was compared to that of the P7.5 promoter of vaccinia virus, as measured by EGFP expression; the fluorescence intensity of EGFP expressed in cells was confirmed by fluorescence microscopy and flow cytometry. PbVV(+) promoter activity was measured by Brucella OMP31 expression. Interaction with the anti-Brucella-OMP31 monoclonal antibody was confirmed by western blotting, and OMP31 mRNA expression was assessed by qRT-PCR. The results of this study will be useful for the further study of effective multivalent vaccines based on rGTPV. This study also provides a theoretical basis for overcoming the problem of low expression of exogenous genes.
27771746	46	50	GTPV	T005	C0206574
27771746	51	64	bidirectional	T080	C1706937
27771746	65	80	promoter region	T114,T123	C0033413
27771746	85	123	goat pox chick embryo-attenuated virus	T005	C0206574
27771746	125	129	GTPV	T005	C0206574
27771746	166	173	vaccine	T121,T129	C0042210
27771746	201	217	immune responses	T042	C0301872
27771746	240	246	genome	T028	C0017428
27771746	271	278	express	T045	C0017262
27771746	279	288	exogenous	T169	C0205228
27771746	289	294	genes	T028	C0017337
27771746	307	312	virus	T005	C0206574
27771746	319	324	ideal	T080	C1512612
27771746	325	331	vector	T114	C0599566
27771746	336	361	recombinant live vaccines	T116,T121,T129	C0034862
27771746	366	385	infectious diseases	T047	C0009450
27771746	389	405	ruminant animals	T015	C0035950
27771746	444	457	bidirectional	T080	C1706937
27771746	458	473	promoter region	T114,T123	C0033413
27771746	477	481	GTPV	T005	C0206574
27771746	506	513	PbVV(±)	T114,T123	C0086860
27771746	515	522	PbVV(±)	T114,T123	C0086860
27771746	542	547	ETF-l	T116,T123	C0082367
27771746	552	558	VITF-3	T116,T123	C0040648
27771746	570	581	transcribed	T045	C0040649
27771746	585	593	opposite	T082	C1521805
27771746	594	604	directions	T082	C0449738
27771746	612	638	recombinant goat pox virus	T005	C0206574
27771746	640	645	rGTPV	T005	C0206574
27771746	683	690	PbVV(+)	T114,T123	C0086860
27771746	705	713	promoter	T114,T123	C0086860
27771746	725	732	enhance	T052	C2349975
27771746	733	747	Brucella OMP31	T116,T123	C1621913
27771746	748	758	expression	T045	C1171362
27771746	774	778	PbVV	T114,T123	C0086860
27771746	797	813	promoter element	T114,T123	C0086860
27771746	826	860	enhanced green fluorescent protein	T116,T130	C1258415
27771746	862	866	EGFP	T116,T130	C1258415
27771746	910	926	PbVV(-) promoter	T114,T123	C0086860
27771746	964	977	P7.5 promoter	T114,T123	C0086860
27771746	981	995	vaccinia virus	T005	C0042216
27771746	1012	1016	EGFP	T116,T130	C1258415
27771746	1017	1027	expression	T045	C1171362
27771746	1033	1055	fluorescence intensity	T059	C0026022
27771746	1059	1063	EGFP	T116,T130	C1258415
27771746	1064	1073	expressed	T045	C1171362
27771746	1077	1082	cells	T025	C0007634
27771746	1100	1123	fluorescence microscopy	T059	C0026022
27771746	1128	1142	flow cytometry	T059	C0016263
27771746	1144	1160	PbVV(+) promoter	T114,T123	C0086860
27771746	1186	1200	Brucella OMP31	T116,T123	C1621913
27771746	1201	1211	expression	T045	C1171362
27771746	1234	1273	anti-Brucella-OMP31 monoclonal antibody	T116,T129	C0003250
27771746	1291	1307	western blotting	T059,T063	C0005863
27771746	1313	1318	OMP31	T116,T123	C1621913
27771746	1319	1334	mRNA expression	T045	C1515670
27771746	1351	1358	qRT-PCR	T063	C1514628
27771746	1426	1435	effective	T080	C1704419
27771746	1436	1456	multivalent vaccines	T121,T129	C1514218
27771746	1466	1471	rGTPV	T005	C0206574
27771746	1552	1562	expression	T045	C1171362
27771746	1566	1575	exogenous	T169	C0205228
27771746	1576	1581	genes	T028	C0017337